Neuropsychopharmacology

Are we ready for a paradigm shift?

Roger Meyer

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The 'paradigm shift' in the title of this article refers to molecular biology. The real challenge to molecular biologists interested in applying their methods to an understanding of psychiatric disorders involves the development of models that account for gene/environment/development interaction. Because of the existence of homologous animal models of additive disorders, as well as a rich body of clinical observations and clinical and behavioral research, and recent data suggesting that chronic exposure to addictive drugs results in changes in gene expression in neurons from behaviorally relevant brain regions, additive disorders offer a serendipitous model (to molecular biologists) that may have relevance to subsequent application in other areas of psychiatry and psychology.

Original languageEnglish (US)
Pages (from-to)169-179
Number of pages11
JournalNeuropsychopharmacology
Volume14
Issue number3
DOIs
StatePublished - Jan 1 1996

Fingerprint

Psychiatry
Behavioral Research
Gene-Environment Interaction
Molecular Models
Molecular Biology
Animal Models
Psychology
Gene Expression
Neurons
Brain
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Psychiatry and Mental health

Cite this

Meyer, Roger. / Neuropsychopharmacology : Are we ready for a paradigm shift?. In: Neuropsychopharmacology. 1996 ; Vol. 14, No. 3. pp. 169-179.
@article{e9a93d949488415b9e09f1f4ed778df9,
title = "Neuropsychopharmacology: Are we ready for a paradigm shift?",
abstract = "The 'paradigm shift' in the title of this article refers to molecular biology. The real challenge to molecular biologists interested in applying their methods to an understanding of psychiatric disorders involves the development of models that account for gene/environment/development interaction. Because of the existence of homologous animal models of additive disorders, as well as a rich body of clinical observations and clinical and behavioral research, and recent data suggesting that chronic exposure to addictive drugs results in changes in gene expression in neurons from behaviorally relevant brain regions, additive disorders offer a serendipitous model (to molecular biologists) that may have relevance to subsequent application in other areas of psychiatry and psychology.",
author = "Roger Meyer",
year = "1996",
month = "1",
day = "1",
doi = "10.1016/0893-133X(95)00074-N",
language = "English (US)",
volume = "14",
pages = "169--179",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "3",

}

Neuropsychopharmacology : Are we ready for a paradigm shift? / Meyer, Roger.

In: Neuropsychopharmacology, Vol. 14, No. 3, 01.01.1996, p. 169-179.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Neuropsychopharmacology

T2 - Are we ready for a paradigm shift?

AU - Meyer, Roger

PY - 1996/1/1

Y1 - 1996/1/1

N2 - The 'paradigm shift' in the title of this article refers to molecular biology. The real challenge to molecular biologists interested in applying their methods to an understanding of psychiatric disorders involves the development of models that account for gene/environment/development interaction. Because of the existence of homologous animal models of additive disorders, as well as a rich body of clinical observations and clinical and behavioral research, and recent data suggesting that chronic exposure to addictive drugs results in changes in gene expression in neurons from behaviorally relevant brain regions, additive disorders offer a serendipitous model (to molecular biologists) that may have relevance to subsequent application in other areas of psychiatry and psychology.

AB - The 'paradigm shift' in the title of this article refers to molecular biology. The real challenge to molecular biologists interested in applying their methods to an understanding of psychiatric disorders involves the development of models that account for gene/environment/development interaction. Because of the existence of homologous animal models of additive disorders, as well as a rich body of clinical observations and clinical and behavioral research, and recent data suggesting that chronic exposure to addictive drugs results in changes in gene expression in neurons from behaviorally relevant brain regions, additive disorders offer a serendipitous model (to molecular biologists) that may have relevance to subsequent application in other areas of psychiatry and psychology.

UR - http://www.scopus.com/inward/record.url?scp=0030000511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030000511&partnerID=8YFLogxK

U2 - 10.1016/0893-133X(95)00074-N

DO - 10.1016/0893-133X(95)00074-N

M3 - Article

VL - 14

SP - 169

EP - 179

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 3

ER -